Results 11 to 20 of about 2,381,877 (194)

Concurrent Endometrial Carcinoma in Patients with a Curettage Diagnosis of Endometrial Hyperplasia

Journal of the Formosan Medical Association, 2009
Endometrial hyperplasia is considered a precursor of endometrial carcinoma, but concurrent endometrial carcinoma in patients with endometrial hyperplasia is seen frequently.
Yu-Li Chen, Wen-Fang Cheng, Ming-Chieh Lin, Chia-Yen Huang, Chang-Yao Hsieh, Chi-An Chen   +5 more
doaj   +3 more sources

Rapid progression of disease in two cases of undifferentiated endometrial carcinoma [PDF]

Gynecologic Oncology Reports, 2019
Undifferentiated endometrial carcinoma, a rare histopathologic diagnosis, has a poor prognosis with high risk of progression during or shortly after completion of adjuvant treatment.
Krista S. Pfaendler, Leslie M. Randall
doaj   +2 more sources

CYLD expression in endometrial carcinoma and correlation with clinicohistopathological parameters

Taiwanese Journal of Obstetrics & Gynecology, 2022
Objective: Endometrial cancer is a threat to women health worldwide. Cylindromatosis (CYLD) enzyme is a tumour suppressor, considered an effective prognostic marker in various malignancies, but its role in endometrial carcinoma is not fully elucidated ...
Vasiliki Papadatou, Stylianos Tologkos, Avgi Tsolou, Theodora-Eleftheria Deftereou, Anastasios Liberis, Grigorios Trypsianis, Triantafyllos Alexiadis, Kyriaki Georgiadi, Christina-Angelika Alexiadi, Christina Nikolaidou, Maria Lambropoulou   +10 more
doaj   +2 more sources

Caracterització del factor de transcripció ERM/ETV5 durant la infiltració miometrial i aproximacions proteòmiques al procés d'invasió en càncer d'endometri [PDF]

, 2009
[cat] El càncer d'endometri és la malaltia ginecològica més comuna i representa la quarta neoplàsia més freqüent en la dona en els països desenvolupats.
Monge i Azemar, Marta
core   +6 more sources

Endometrial Hyperplasia and Endometrial Carcinoma [PDF]

, 2020
Endometrial hyperplasia and endometrial carcinoma are rare in young women, but the incidence is continually increasing in developed countries due to obesity and metabolic diseases.
Wimberger, Pauline, Maren Goeckenjan, von Wolff, Michael, Michael von Wolff, Goeckenjan, Maren, Pauline Wimberger   +5 more
core   +2 more sources

Single-cell transcriptomic analysis highlights origin and pathological process of human endometrioid endometrial carcinoma

Nature Communications, 2022
Endometrial cancers are complex ecosystems composed of cells with distinct phenotypes, genotypes, and epigenetic states. Current models do not adequately reflect oncogenic origin and pathological progression in patients.
Xiaojun Ren, Jianqing Liang, Yiming Zhang, Ning Jiang, Yuhui Xu, Mengdi Qiu, Yi-Qin Wang, Bing Zhao, Xiao-Jun Chen   +8 more
semanticscholar   +1 more source

A first-in-class POLRMT specific inhibitor IMT1 suppresses endometrial carcinoma cell growth

Cell Death and Disease, 2023
Exploring novel molecularly-targeted therapies for endometrial carcinoma is important. The current study explored the potential anti-endometrial carcinoma activity by a first-in-class POLRMT (RNA polymerase mitochondrial) inhibitor IMT1.
Shu-ping Li, Li Ou, Yan Zhang, Fang-rong Shen, You-guo Chen   +4 more
doaj   +1 more source

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

International Journal of Gynecological Cancer, 2020
A European consensus conference on endometrial carcinoma was held in 2014 to produce multi-disciplinary evidence-based guidelines on selected questions.
N. Concin, X. Matías-Guiu, I. Vergote, D. Cibula, M. Mirza, S. Marnitz, J. Ledermann, T. Bosse, Cyrus Chargari, A. Fagotti, C. Fotopoulou, A. González-Martín, S. Lax, D. Lorusso, C. Marth, P. Morice, Remi A. Nout, D. O'Donnell, D. Querleu, M. Raspollini, J. Sehouli, A. Sturdza, Alexandra Taylor, A. Westermann, P. Wimberger, N. Colombo, F. Planchamp, C. Creutzberg   +27 more
semanticscholar   +1 more source

High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma

BMC Cancer, 2022
S100A2, a member of the S100 protein family, is abnormally expressed and plays a vital role in multiple cancers. However, little is known about the clinical significance of S100A2 in endometrial carcinoma.
Qin-Zheng Zhang, Tian-Xiang Xia, Chenxiang Qi, Jun Du, Chun-Ping Ye   +4 more
semanticscholar   +1 more source

The Expression and Clinical Significance of Sphingosine Kinase 1 and Vascular Endothelial Growth Factor in Endometrial Carcinoma

Emergency Medicine International, 2022
The aim of the study is to investigate the expression of sphingosine kinase 1 (SPHK1) and vascular endothelial growth factor (VEGF) in patients with endometrial carcinoma and its clinical significance. The tissues of 86 cases of patients with endometrial
Hong Yu, null Dejizhuoga, Wei Huang, Donglian Wang, null Gamaquzhen, Xiaomin Jia, Hao Feng   +6 more
doaj   +1 more source